Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Gross Profit (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Gross Profit for 4 consecutive years, with $692687.0 as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 7.32% to $692687.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, down 42.72% year-over-year, with the annual reading at $1.9 million for FY2025, 42.72% down from the prior year.
  • Gross Profit for Q4 2025 was $692687.0 at bioAffinity Technologies, up from $503855.0 in the prior quarter.
  • The five-year high for Gross Profit was $989942.0 in Q2 2024, with the low at $834.0 in Q1 2023.
  • Average Gross Profit over 4 years is $407310.5, with a median of $485737.0 recorded in 2025.
  • The sharpest move saw Gross Profit surged 99774.1% in 2024, then plummeted 74.45% in 2025.
  • Over 4 years, Gross Profit stood at $2171.0 in 2022, then soared by 25164.72% to $548497.0 in 2023, then increased by 17.67% to $645427.0 in 2024, then rose by 7.32% to $692687.0 in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $692687.0, $503855.0, and $252881.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.